Viewing Study NCT01284868

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:53 PM
Ignite Modification Date: 2026-01-04 @ 12:21 PM
Study NCT ID: NCT01284868
Status: COMPLETED
Last Update Posted: 2013-07-03
First Post: 2011-01-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers View
None Pharmacodynamics of Mirabegron View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Mechanisms of Pharmacological Action View
None Pharmacodynamics View
None Pharmacokinetics View